{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "28245170", "DateCompleted": {"Year": "2018", "Month": "03", "Day": "30"}, "DateRevised": {"Year": "2024", "Month": "01", "Day": "09"}, "Article": {"ArticleDate": [{"Year": "2016", "Month": "12", "Day": "21"}], "Language": ["eng"], "ELocationID": ["10.3727/096504016X14816352324532"], "Journal": {"ISSN": "1555-3906", "JournalIssue": {"Volume": "25", "Issue": "6", "PubDate": {"Year": "2017", "Month": "Jul", "Day": "05"}}, "Title": "Oncology research", "ISOAbbreviation": "Oncol Res"}, "ArticleTitle": "Crude Flavonoid Extract of Medicinal Herb <i>Zingibar officinale</i> Inhibits Proliferation and Induces Apoptosis in Hepatocellular Carcinoma Cells.", "Pagination": {"StartPage": "897", "EndPage": "912", "MedlinePgn": "897-912"}, "Abstract": {"AbstractText": ["There is an urgent need to improve the clinical management of hepatocellular carcinoma (HCC), one of the most common causes of global cancer-related deaths. Zingibar officinale is a medicinal herb used throughout history for both culinary and medicinal purposes. It has antioxidant, anticarcinogenic, and free radical scavenging properties. Previously, we proved that the crude flavonoid extract of Z. officinale (CFEZO) inhibited growth and induced apoptosis in several cancer cell lines. However, the effect of the CFEZO on an HCC cell line has not yet been evaluated. In this study, we explored the anticancer activity of CFEZO against an HCC cell line, HepG2. CFEZO significantly inhibited proliferation and induced apoptosis in HepG2 cells. Typical apoptotic morphological and biochemical changes, including cell shrinkage and detachment, nuclear condensation and fragmentation, DNA degradation, and comet tail formation, were observed after treatments with CFEZO. The apoptogenic activity of CFEZO involved induction of ROS, depletion of GSH, disruption of the mitochondrial membrane potential, activation of caspase 3/9, and an increase in the Bax/Bcl-2 ratio. CFEZO treatments induced upregulation of p53 and p21 expression and downregulation of cyclin D1 and cyclin-dependent kinase-4 expression, which were accompanied by G2/M phase arrest. These findings suggest that CFEZO provides a useful foundation for studying and developing novel chemotherapeutic agents for the treatment of HCC."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [], "LastName": "Elkady", "ForeName": "Ayman I", "Initials": "AI"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Abu-Zinadah", "ForeName": "Osama A", "Initials": "OA"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Hussein", "ForeName": "Rania Abd El Hamid", "Initials": "RAEH"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Oncol Res", "NlmUniqueID": "9208097", "ISSNLinking": "0965-0407"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Flavonoids"}, {"RegistryNumber": "0", "NameOfSubstance": "Reactive Oxygen Species"}, {"RegistryNumber": "EC 3.4.22.-", "NameOfSubstance": "CASP9 protein, human"}, {"RegistryNumber": "EC 3.4.22.-", "NameOfSubstance": "Caspase 3"}, {"RegistryNumber": "EC 3.4.22.-", "NameOfSubstance": "Caspase 9"}, {"RegistryNumber": "GAN16C9B8O", "NameOfSubstance": "Glutathione"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": ["drug therapy", "metabolism", "pathology"], "DescriptorName": "Carcinoma, Hepatocellular"}, {"QualifierName": ["metabolism"], "DescriptorName": "Caspase 3"}, {"QualifierName": ["metabolism"], "DescriptorName": "Caspase 9"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": ["drug effects"], "DescriptorName": "DNA Damage"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Flavonoids"}, {"QualifierName": ["chemistry"], "DescriptorName": "Zingiber officinale"}, {"QualifierName": ["metabolism"], "DescriptorName": "Glutathione"}, {"QualifierName": [], "DescriptorName": "HeLa Cells"}, {"QualifierName": [], "DescriptorName": "Hep G2 Cells"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy", "metabolism", "pathology"], "DescriptorName": "Liver Neoplasms"}, {"QualifierName": [], "DescriptorName": "MCF-7 Cells"}, {"QualifierName": ["drug effects"], "DescriptorName": "Membrane Potential, Mitochondrial"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["metabolism"], "DescriptorName": "Reactive Oxygen Species"}], "CoiStatement": "The authors declare no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69\u201390.", "ArticleIdList": ["21296855"]}, {"Citation": "El-Serag HB, Davila JA, Petersen NJ, Mc-Glynn KA. The continuing increase in the incidence of hepatocellular carcinoma in the United States: An update. Ann Intern Med. 2003;139:817\u201323.", "ArticleIdList": ["14623619"]}, {"Citation": "Llovet JM, Hernandez-Gea V. Hepatocellular carcinoma: Reasons for phase III failure and novel perspectives on trial design. Clin Cancer Res. 2014;20:2072\u20139.", "ArticleIdList": ["24589894"]}, {"Citation": "Peck-Radosavljevic M. Drug therapy for advanced-stage liver cancer. Liver Cancer 2014;3:125\u201331.", "ArticleIdList": ["PMC4057791", "24945003"]}, {"Citation": "Jelic S, Sotiropoulos GC. Hepatocellular carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21(Suppl 5):v59\u2013v64.", "ArticleIdList": ["20555104"]}, {"Citation": "Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell 2011;144:646\u201374.", "ArticleIdList": ["21376230"]}, {"Citation": "Wong RS. Apoptosis in cancer: From pathogenesis to treatment. J Exp Clin Cancer Res. 2011;30:87.", "ArticleIdList": ["PMC3197541", "21943236"]}, {"Citation": "Kroemer G, Galluzzi L, Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol Rev. 2007;87:99\u2013163.", "ArticleIdList": ["17237344"]}, {"Citation": "Rasola A, Bernardi P. The mitochondrial permeability transition pore and its involvement in cell death and in disease pathogenesis. Apoptosis 2007;12:815\u201333.", "ArticleIdList": ["17294078"]}, {"Citation": "Green DR, Kroemer G. The pathophysiology of mitochondrial cell death. Science 2004;305:626\u20139.", "ArticleIdList": ["15286356"]}, {"Citation": "Reed JC. Mechanisms of apoptosis. Am J Pathol. 2000;157:1415\u201326.", "ArticleIdList": ["PMC1885741", "11073801"]}, {"Citation": "Cruchten SV, Den Broeck WV. Morphological and biochemical aspects of apoptosis, oncosis and necrosis. Anat Histol Embryol. 2002;31:214\u201323.", "ArticleIdList": ["12196263"]}, {"Citation": "Fruehauf JP, Meyskens FL Jr. Reactive oxygen species: A breath of life or death? Clin Cancer Res. 2007;13:789\u201394.", "ArticleIdList": ["17289868"]}, {"Citation": "Ott M, Gogvadze V, Orrenius S, Zhivotovsky B. Mitochondria, oxidative stress and cell death. Apoptosis 2007;12:913\u201322.", "ArticleIdList": ["17453160"]}, {"Citation": "Glasauer A, Chandel NS. Targeting antioxidants for cancer therapy. Biochem Pharmacol. 2014;92:90\u2013101.", "ArticleIdList": ["25078786"]}, {"Citation": "Pelicano H, Carney D, Huang P. ROS stress in cancer cells and therapeutic implications. Drug Resist Updat. 2004;7:97\u2013110.", "ArticleIdList": ["15158766"]}, {"Citation": "Zhou Y, Hileman EO, Plunkett W, Keating MJ, Huang P. Free radical stress in chronic lymphocytic leukemia cells and its role in cellular sensitivity to ROS-generating anticancer agents. Blood 2003;101:4098\u2013104.", "ArticleIdList": ["12531810"]}, {"Citation": "Franco R, Cidlowski JA. Apoptosis and glutathione: Beyond an antioxidant. Cell Death Differ. 2009;16:1303\u201314.", "ArticleIdList": ["19662025"]}, {"Citation": "Lushchak VI. Glutathione homeostasis and functions: Potential targets for medical interventions. J Amino Acids 2012;2012:736837.", "ArticleIdList": ["PMC3303626", "22500213"]}, {"Citation": "Traverso N, Ricciarelli R, Nitti M, Marengo B, Furfaro AL, Pronzato MA, Marinari UM, Domenicotti C. Role of glutathione in cancer progression and chemoresistance. Oxid Med Cell Longev. 2012;2013:972913.", "ArticleIdList": ["PMC3673338", "23766865"]}, {"Citation": "Backos DS, Franklin CC, Reigan P. The role of glutathione in brain tumor drug resistance. Biochem Pharmacol. 2012;83:1005\u201312.", "ArticleIdList": ["22138445"]}, {"Citation": "Liu FL, Hsu JL, Lee YJ, Dong YS, Kung FL, Chen CS, Guh JH. Calanquinone A induces anti-glioblastoma activity through glutathione-involved DNA damage and AMPK activation. Eur J Pharmacol. 2014;730:90\u2013101.", "ArticleIdList": ["PMC4249740", "24607408"]}, {"Citation": "Baliga MS, Haniadka R, Pereira MM, D\u2019Souza JJ, Pallaty PL, Bhat HP, Popuri S. Update on the chemopreventive effects of ginger and its phytochemicals. Crit Rev Food Sci Nutr. 2011;51:499\u2013523.", "ArticleIdList": ["21929329"]}, {"Citation": "Park EJ, Pizzuto JM. Botanicals in cancer chemoprevention. Cancer Metastasis Rev. 2002;21:231\u201355.", "ArticleIdList": ["12549763"]}, {"Citation": "Ghasemzadeh A, Jaafar HZ, Rahmat A. Identification and concentration of some flavonoid components in Malaysian young ginger (Zingiber officinale Roscoe) varieties by a high performance liquid chromatography method. Molecules 2010;15:6231\u201343.", "ArticleIdList": ["PMC6257699", "20877219"]}, {"Citation": "Han JS, Lee S, Kim HY, Lee CH. MS-based metabolite profiling of aboveground and root components of Zingiber mioga and officinale. Molecules 2015;20:16170\u201385.", "ArticleIdList": ["PMC6332244", "26404226"]}, {"Citation": "Chahar MK, Sharma N, Dobhal MP, Joshi YC. Flavonoids: A versatile source of anticancer drugs. Pharmacogn Rev. 2011;5:1\u201312.", "ArticleIdList": ["PMC3210013", "22096313"]}, {"Citation": "Koz\u0142owska A, Szostak-W\u0119gierek D. Flavonoids: Food sources and health benefits. Rocz Panstw Zakl Hig. 2014;65:79\u201385.", "ArticleIdList": ["25272572"]}, {"Citation": "Kale A, Gawande S, Kotwal S. Cancer phytotherapeutics: Role for flavonoids at the cellular level. Phytother Res. 2008;22:567\u201377.", "ArticleIdList": ["18398903"]}, {"Citation": "Elkady AI, Hussein RA, Abu-Zinadah AO. Effects of crude extracts from medicinal herbs Rhazya stricta and Zingiber officinale on growth and proliferation of human brain cancer cell line in vitro. Biomed Res Int. 2014;2014:260210.", "ArticleIdList": ["PMC4130191", "25136570"]}, {"Citation": "Elkady AI, Hussein RA, Abu-Zinadah AO. Differential control of growth, apoptotic activity and gene expression in human colon cancer cells by extracts derived from medicinal herbs, Rhazya stricta and Zingiber officinale and their combination. World J Gastroenterol. 2014;20:15275\u201388.", "ArticleIdList": ["PMC4223261", "25386076"]}, {"Citation": "Elkady AI, Hussein RA, El-Assouli SM. Mechanism of action of Nigella sativa on human colon cancer cells: The suppression of AP-1 and NF-\u03baB transcription factors and the induction of cytoprotective genes. Asian Pac J Cancer Prev. 2015;16:7943\u201357.", "ArticleIdList": ["26625825"]}, {"Citation": "Antosiewicz J, Ziolkowski W, Kar S, Powolny AA, Singh SV. Role of reactive oxygen intermediates in cellular responses to dietary cancer chemopreventive agents. Planta Med. 2008;74:1570\u20139.", "ArticleIdList": ["PMC2574970", "18671201"]}, {"Citation": "Nagata S. Apoptotic DNA fragmentation. Exp Cell Res. 2000;256:12\u20138.", "ArticleIdList": ["10739646"]}, {"Citation": "Vermeulen K, Van Bockstaele DR, Berneman ZN. The cell cycle: A review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif. 2003;36:131\u201349.", "ArticleIdList": ["PMC6496723", "12814430"]}, {"Citation": "Khan N, Afaq F, Mukhtar H. Apoptosis by dietary factors: The suicide solution for delaying cancer growth. Carcinogenesis 2007;28:233\u20139.", "ArticleIdList": ["17151090"]}, {"Citation": "Archana M, Bastian, Yogesh TL, Kumaraswamy KL. Various methods available for detection of apoptotic cells\u2014A review. Indian J Cancer 2013;50:274\u201383.", "ArticleIdList": ["24061471"]}, {"Citation": "Oh SH, Lim SC. A rapid and transient ROS generation by cadmium triggers apoptosis via caspase-dependent pathway in HepG2 cells and this is inhibited through N-acetyl cysteine mediated catalase upregulation. Toxicol Appl Pharmacol. 2006;212:212\u201323.", "ArticleIdList": ["16169029"]}, {"Citation": "Balendiran GK, Dabur R, Fraser D. The role of glutathione in cancer. Cell Biochem Funct. 2004;22:343\u201352.", "ArticleIdList": ["15386533"]}, {"Citation": "Park WH, Kim SH. MAPK inhibitors augment gallic acid-induced A549 lung cancer cell death through the enhancement of glutathione depletion. Oncol Rep. 2013;30:513\u20139.", "ArticleIdList": ["23660987"]}, {"Citation": "Huang ZZ, Chen C, Zeng Z, Yang H, Oh J, Chen L, Lu SC. Mechanism and significance of increased glutathione level in human hepatocellular carcinoma and liver regeneration. FASEB J. 2001;15:19\u201321.", "ArticleIdList": ["11099488"]}, {"Citation": "Ye CG, Yeung JH, Huang GL, Cui P, Wang J, Zou Y, Zhang XN, He ZW, Cho CH. Increased glutathione and mitogen-activated protein kinase phosphorylation are involved in the induction of doxorubicin resistance in hepatocellular carcinoma cells. Hepatol Res. 2013;43:289\u201399.", "ArticleIdList": ["22882382"]}, {"Citation": "Lachenmayer A, Alsinet C, Chang CY, Llovet JM. Molecular approaches to treatment of hepatocellular carcinoma. Dig Liver Dis. 2010;42(Suppl 3):S264\u201372.", "ArticleIdList": ["PMC3693074", "20547313"]}, {"Citation": "Walensky L. BCL-2 in the crosshairs: Tipping the balance of life and death. Cell Death Differ. 2006;13:1339\u201350.", "ArticleIdList": ["16763614"]}, {"Citation": "Sasi N, Hwang M, Jaboin J, Csiki I, Lu B. Regulated cell death pathways: New twists in modulation of BCL2 family function. Mol Cancer Ther. 2009;8:1421\u20139.", "ArticleIdList": ["PMC3091595", "19509269"]}, {"Citation": "Adams J, Cory S. The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 2007;26:1324\u201337.", "ArticleIdList": ["PMC2930981", "17322918"]}, {"Citation": "Losert D, Pratscher B, Soutschek J, Geick A, Vornlocher HP, Muller M, Wacheck V. Bcl-2 downregulation sensitizes nonsmall cell lung cancer cells to cisplatin, but not to docetaxel. Anticancer Drugs 2007;18:755\u201361.", "ArticleIdList": ["17581297"]}, {"Citation": "Yasuhara S, Zhu Y, Matsui T, Tipirneni N, Yasuhara Y, Kaneki M, Rosenzweig A, Martyn JA. Comparison of comet assay, electron microscopy, and flow cytometry for detection of apoptosis. J Histochem Cytochem. 2003;51:873\u201385.", "ArticleIdList": ["12810838"]}, {"Citation": "Chakraborty S, Kundu T, Dey S, Bhattacharya KR, Siddiqi M, Roy M. Tea-induced apoptosis in human leukemia K562 cells as assessed by comet formation. Asian Pacific J Cancer Prev. 2006;7:201\u20137.", "ArticleIdList": ["16839211"]}, {"Citation": "Zhou BB, Elledge SJ. The DNA damage response: Putting checkpoints in perspective. Nature 2000;408:433\u20139.", "ArticleIdList": ["11100718"]}, {"Citation": "Amin AR, Karpowicz PA, Carey TE, Arbiser J, Nahta R, Chen ZG, Dong JT, Kucuk O, Khan GN, Huang GS, Mi S, Lee HY, Reichrath J, Honoki K, Georgakilas AG, Amedei A, Amin A, Helferich B, Boosani CS, Ciriolo MR, Chen S, Mohammed SI, Azmi AS, Keith WN, Bhakta D, Halicka D, Niccolai E, Fujii H, Aquilano K, Ashraf SS, Nowsheen S, Yang X, Bilsland A, Shin DM. Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds. Semin Cancer Biol. 2015;35(Suppl):S55\u201377.", "ArticleIdList": ["PMC4561219", "25749195"]}, {"Citation": "Selivanova G. Wild type p53 reactivation: From lab bench to clinic. FEBS Lett. 2014;588:2628\u201338.", "ArticleIdList": ["24726725"]}, {"Citation": "Vousden KH, Prives C. Blinded by the light: The growing complexity of p53. Cell 2009;137:413\u201331.", "ArticleIdList": ["19410540"]}, {"Citation": "Sabapathy K. The contrived mutant p53 oncogene\u2014Beyond loss of functions. Front Oncol. 2015;5:276.", "ArticleIdList": ["PMC4674554", "26697411"]}, {"Citation": "Meng X, Franklin DA, Dong J, Zhang Y. MDM2\u2013p53 pathway in hepatocellular carcinoma. Cancer Res. 2014;74:7161\u20137.", "ArticleIdList": ["PMC4504428", "25477334"]}, {"Citation": "Kirstein MM, Vogel A. The pathogenesis of hepatocellular carcinoma. Dig Dis. 2014;32:545\u201353.", "ArticleIdList": ["25034287"]}, {"Citation": "Pietsch EC, Sykes SM, McMahon SB, Murphy ME. The p53 family and programmed cell death. Oncogene 2008;27:6507\u201321.", "ArticleIdList": ["PMC2657599", "18955976"]}, {"Citation": "Chi SW. Structural insights into the transcription-independent apoptotic pathway of p53. BMB Rep. 2014;47:167\u201372.", "ArticleIdList": ["PMC4163879", "24499665"]}, {"Citation": "Cai X, Hu X, Cai B, Wang Q, Li Y, Tan X, Hu H, Chen X, Huang J, Cheng J, Jing X. Metformin suppresses hepatocellular carcinoma cell growth through induction of cell cycle G1/G0 phase arrest and p21CIP and p27KIP expression and downregulation of cyclin D1 in vitro and in vivo. Oncol Rep. 2013;30:2449\u201357.", "ArticleIdList": ["24008375"]}, {"Citation": "Kao JT, Chuah SK, Huang CC, Chen CL, Wang CC, Hung CH, Chen CH, Wang JH, Lu SN, Lee CM, Changchien CS, Hu TH. P21/WAF1 is an independent survival prognostic factor for patients with hepatocellular carcinoma after resection. Liver Int. 2007;27:772\u201381.", "ArticleIdList": ["17617120"]}, {"Citation": "Abukhdeir AM, Park BH. p21 and p27: Roles in carcinogenesis and drug resistance. Expert Rev Mol Med. 2008;10:e19.", "ArticleIdList": ["PMC2678956", "18590585"]}, {"Citation": "Masaki T, Shiratori Y, Rengifo W, Igarashi K, Yamagata M, Kurokohchi K, Uchida N, Miyauchi Y, Yoshiji H, Watanabe S, Omata M, Kuriyama S. Comparative study of hepatocellular carcinoma versus cirrhosis. Hepatology 2003;37:534\u201343.", "ArticleIdList": ["12601350"]}, {"Citation": "Relja B, Meder F, Wilhelm K, Henrich D, Marzi I, Lehnert M. Simvastatin inhibits cell growth and induces apoptosis and G0/G1 cell cycle arrest in hepatic cancer cells. Int J Mol Med. 2010;26:735\u201341.", "ArticleIdList": ["20878096"]}, {"Citation": "Yang K, Hitomi M, Stacey DW. Variations in cyclin D1 levels through the cell cycle determine the proliferative fate of a cell. Cell Div. 2006;1:32.", "ArticleIdList": ["PMC1769361", "17176475"]}, {"Citation": "Yang XG, Bao YL, Huang YX, Sun LG, Zhang YW, Yu CL, Wu Y, Li YX. 6-[(1-naphthylmethyl)sulfanyl]-9H-purine induces G2/M phase arrest and apoptosis in human hepatocellular carcinoma HepG2 cells. Eur J Pharmacol. 2012;695:27\u201333.", "ArticleIdList": ["23000392"]}, {"Citation": "Qian JQ, Sun P, Pan ZY, Fang ZZ. Annonaceous acetogenins reverses drug resistance of human hepatocellular carcinoma BEL-7402/5-FU and HepG2/ADM cell lines. Int J Clin Exp Pathol. 2015;8:11934\u201344.", "ArticleIdList": ["PMC4637767", "26617951"]}, {"Citation": "Kong Y, Li F, Nian Y, Zhou Z, Yang R, Qiu MH, Chen C. KHF16 is a leading structure from Cimicifuga foetida that suppresses breast cancer partially by inhibiting the NF-kB signaling pathway. Theranostics 2016;6:875\u201386.", "ArticleIdList": ["PMC4860895", "27162557"]}, {"Citation": "Gonz\u00e1lez-Sarr\u00edas A, Ma H, Edmonds ME, Seeram NP. Maple polyphenols, ginnalins A\u2013C, induce S- and G2/M-cell cycle arrest in colon and breast cancer cells mediated by decreasing cyclins A and D1 levels. Food Chem. 2013;136:636\u201342.", "ArticleIdList": ["23122108"]}, {"Citation": "Burgess A, Wigan M, Giles N, Depinto W, Gillespie P, Stevens F, Gabrielli B. Inhibition of S/G2 phase CDK4 reduces mitotic fidelity. J Biol Chem. 2006;281:9987\u201395.", "ArticleIdList": ["16476733"]}, {"Citation": "Qiu P, Dong P, Guan H, Li S, Ho CT, Pan MH, McClements DJ, Xiao H. Inhibitory effects of 5-hydroxy polymethoxyflavones on colon cancer cells. Mol Nutr Food Res. 2010;Suppl 2:S244\u201352.", "ArticleIdList": ["20397199"]}]}], "History": [{"Year": "2017", "Month": "3", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "3", "Day": "31", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "3", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "7", "Day": "5"}], "PublicationStatus": "ppublish", "ArticleIdList": ["28245170", "PMC7841261", "10.3727/096504016X14816352324532"]}}]}